Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
New frontiers in the treatment of liposarcoma, a therapeutically resistant malignant cohort.
[pleomorphic liposarcoma]
The
adipogenic
origin-derived
liposarcoma
(
LPS
)
family
is
the
most
common
soft
tissue
sarcoma
histological
subtype
.
This
group
is
composed
of
three
categories
as
per
the
2002
WHO
guidelines
:
(
1
)
well-differentiated
and
dedifferentiated
liposarcoma
(
WDLPS
/
DDLPS
)
;
(
2
)
myxoid
and
round
cell
liposarcoma
(
MLS
and
RCL
)
;
and
(
3
)
pleomorphic
liposarcoma
(
PLS
)
.
While
clustered
together
,
these
histological
subtypes
are
widely
diverse
in
their
clinical
,
pathological
,
and
molecular
characteristics
.
In
general
,
surgery
still
remains
the
mainstay
of
LPS
therapy
and
the
only
approach
offering
the
potential
of
cure
.
Effective
therapeutic
strategies
for
locally
advanced
and
metastatic
disease
are
currently
lacking
and
are
crucially
needed
.
With
the
current
gradually
increasing
knowledge
of
LPS
genetic-
and
epigenetic-associated
deregulations
,
the
ultimate
goal
is
to
develop
drugs
that
can
specifically
eliminate
LPS
cells
while
sparing
normal
tissues
.
This
tumor
-tailored
target-orientated
approach
will
hopefully
result
in
a
significant
improvement
in
the
outcome
of
patients
suffering
from
these
poor
prognosis
malignancies
.
Diseases
Validation
Diseases presenting
"a significant improvement in the outcome of patients suffering from these poor prognosis malignancies"
symptom
pleomorphic liposarcoma
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom